Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

Abstract: Polyunsaturated fatty acid (PUFA) levels (an index of the amount of substrate available for lipid peroxidation) were measured in several brain regions from patients who died with Parkinson's disease and age‐matched control human postmortem brains. PUFA levels were reduced in parkinsonian substantia nigra compared to other brain regions and to control tissue. However, basal malondialdehyde (MDA; an intermediate in the lipid peroxidation process) levels were increased in parkinsonian nigra compared with other parkinsonian brain regions and control tissue. Expressing basal MDA levels in terms of PUFA content, the difference between parkinsonian and control substantia nigra was even more pronounced. Stimulating MDA production by incubating tissue with FeSO4 plus ascorbic acid, FeSO4 plus H2O2, or air alone produced lower MDA levels in the parkinsonian substantia nigra, probably reflecting the lower PUFA content. These results may indicate that an increased level of lipid peroxidation continues to occur in the parkinsonian nigra up to the time of death, perhaps because of continued exposure to excess free radicals derived from some endogenous or exogenous neurotoxic species.

[1]  P. Riederer,et al.  Biochemical fundamentals of Parkinson's disease. , 1988, The Mount Sinai journal of medicine, New York.

[2]  C. Marsden,et al.  INCREASED NIGRAL IRON CONTENT IN POSTMORTEM PARKINSONIAN BRAIN , 1987, The Lancet.

[3]  C. Marsden,et al.  in vitro characterisation of dopamine receptors in the superior colliculus of the rat , 1987, Neuropharmacology.

[4]  C. Marsden,et al.  LIPID PEROXIDATION AS CAUSE OF NIGRAL CELL DEATH IN PARKINSON'S DISEASE , 1986, The Lancet.

[5]  Voon Wee Yong,et al.  Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients , 1986, Neuroscience Letters.

[6]  W. Nicklas,et al.  Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium , 1986, Journal of neurochemistry.

[7]  G. Krishna,et al.  Formation of superoxide and hydroxyl radicals from 1-methyl-4-phenylpyridinium ion (MPP+): reductive activation by NADPH cytochrome P-450 reductase. , 1986, Biochemical and biophysical research communications.

[8]  S. Kish,et al.  Brain glutathione peroxidase in neurodegenerative disorders. , 1986, Neurochemical pathology.

[9]  S. Markey,et al.  MPTP-Induced Parkinsonian Syndromes in Humans and Animals , 1986 .

[10]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[11]  P. Riederer,et al.  Dopaminforschung heute und morgen - L-Dopa in der Zukunft , 1985 .

[12]  Grahame-Smith Dg,et al.  Catecholamine toxicity : a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease , 1984 .

[13]  D. Graham.  Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. , 1984, Neurotoxicology.

[14]  D. Godin,et al.  Parkinson's disease: A disorder due to nigral glutathione deficiency? , 1982, Neuroscience Letters.

[15]  R. Wurtman,et al.  Long‐term administration of L‐DOPA does not damage dopaminergic neurons in the mouse , 1981, Neurology.

[16]  S. Rehncrona,et al.  Peroxidative Changes in Brain Cortical Fatty Acids and Phospholipids, as Characterized During Fe2+‐ and Ascorbic Acid‐Stimulated Lipid Peroxidation In Vitro , 1980, Journal of neurochemistry.

[17]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[18]  D. Graham,et al.  Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. , 1978, Molecular pharmacology.

[19]  D. Graham.  Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. , 1978, Molecular pharmacology.

[20]  M. V. Van Woert,et al.  Brain peroxidase and catalase in Parkinson disease. , 1975, Archives of neurology.

[21]  K. Earle.  Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. , 1968, Journal of neuropathology and experimental neurology.

[22]  J. MacGee.  Enzymatic determination of polyunsaturated fatty acids. , 1959 .

[23]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[24]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.